Irini Grapsa

564 total citations
11 papers, 411 citations indexed

About

Irini Grapsa is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Irini Grapsa has authored 11 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Irini Grapsa's work include Multiple Myeloma Research and Treatments (9 papers), Cancer Treatment and Pharmacology (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Irini Grapsa is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Cancer Treatment and Pharmacology (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Irini Grapsa collaborates with scholars based in Greece and Spain. Irini Grapsa's co-authors include Efstathios Kastritis, Μαρία Ρούσσου, Meletios Α. Dimopoulos, Erasmia Psimenou, Evangelos Terpos, Magdalini Migkou, Charis Matsouka, Dimitra Gika, Dimitrios Christoulas and Maria Gavriatopoulou and has published in prestigious journals such as Blood, Haematologica and European Journal Of Haematology.

In The Last Decade

Irini Grapsa

11 papers receiving 401 citations

Peers

Irini Grapsa

HEMAT

ONCOL

GENET

PPCH

C. Matsouka Greece

Lucia Ahlberg Sweden

Ken Romeril New Zealand

Ulf Christian Frølund Denmark

J. Timothy Caldwell United States

F. Meeus France

Jennifer Yui United States

Rony Abou Jawde United States

Ann Birner United States

M. Cole‐Sinclair Australia

C. Matsouka Greece

Irini Grapsa

322 ×0.9

HEMAT

267 ×0.8

149 ×0.8

ONCOL

83 ×1.7

GENET

30 ×0.7

PPCH

Citations per year, relative to Irini Grapsa Irini Grapsa (= 1×) peers C. Matsouka

Countries citing papers authored by Irini Grapsa

Since Specialization

Citations

This map shows the geographic impact of Irini Grapsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irini Grapsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irini Grapsa more than expected).

Fields of papers citing papers by Irini Grapsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irini Grapsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irini Grapsa. The network helps show where Irini Grapsa may publish in the future.

Co-authorship network of co-authors of Irini Grapsa

This figure shows the co-authorship network connecting the top 25 collaborators of Irini Grapsa. A scholar is included among the top collaborators of Irini Grapsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irini Grapsa. Irini Grapsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kastritis, Efstathios, Μαρία Ρούσσου, Μαρία Γκοτζαμανίδου, et al.. (2011). Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens. Leukemia & lymphoma. 52(12). 2299–2303. 24 indexed citations

Papaconstantinou, Ioannis, et al.. (2011). Successful Treatment of a Severe Case of Fournier's Gangrene Complicating a Perianal Abscess. Case Reports in Medicine. 2011. 1–4. 8 indexed citations

Ρούσσου, Μαρία, Efstathios Kastritis, Dimitrios Christoulas, et al.. (2010). Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents. Leukemia Research. 34(10). 1395–1397. 53 indexed citations

Dimopoulos, Meletios Α., Dimitrios Christoulas, Μαρία Ρούσσου, et al.. (2010). Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment. European Journal Of Haematology. 85(1). 1–5. 57 indexed citations

Dimopoulos, Meletios Α., Μαρία Ρούσσου, Maria Gavriatopoulou, et al.. (2009). Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors. Clinical Lymphoma & Myeloma. 9(4). 302–306. 78 indexed citations

Ρούσσου, Μαρία, Efstathios Kastritis, Dimitrios Christoulas, et al.. (2009). Reversibility of Renal Failure in Newly Diagnosed Patients with Multiple Myeloma and the Role of Novel Agents.. Blood. 114(22). 955–955. 3 indexed citations

Ρούσσου, Μαρία, Efstathios Kastritis, Magdalini Migkou, et al.. (2008). Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens. Leukemia & lymphoma. 49(5). 890–895. 57 indexed citations

Dimopoulos, Meletios Α., Μαρία Ρούσσου, Efstathios Kastritis, et al.. (2008). Reversibility of Renal Impairment of Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Identification of Predictive Factors.. Blood. 112(11). 1725–1725. 3 indexed citations

Kastritis, Efstathios, Αchilles Anagnostopoulos, Μαρία Ρούσσου, et al.. (2007). Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica. 92(4). 546–549. 113 indexed citations

10.

Ρούσσου, Μαρία, Efstathios Kastritis, Αchilles Anagnostopoulos, et al.. (2007). Treatment of Patients with Multiple Myeloma Complicated by Renal Failure with Bortezomib - Based Regimens.. Blood. 110(11). 2739–2739. 2 indexed citations

11.

Grapsa, Irini & D.G. Oreopoulos. (1996). Practical ethical issues of dialysis in the elderly.. PubMed. 16(4). 339–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact